NIH hopes to win over skeptics with drug repurposing successes

07/18/2013 | Nature (free content)

Nine awardees will split $12.7 million from the NIH to find new targets for eight abandoned drug compounds. Critics say the National Center for Advancing Translational Sciences program has low odds of succeeding because drugmakers that developed the compounds abandoned them for a reason. Proponents say even moderate success will yield substantial return on the investment.

View Full Article in:

Nature (free content)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN